Skip to Main Content

Top of the morning to you, and a fine one it is. Despite gray skies and a bit of a drizzle, our spirits are sunny today. And why not? As the Morning Mayor taught us: Every day should be unwrapped like a precious gift. So while you tug on the ribbon, we will brew a cup of stimulation and forage for a few interesting items. Speaking of which, here is the latest batch of tidbits to get you started on your journey. We hope all goes well today and you exceed your to-do list. Stay in touch, and stay safe. …

For those closely watching the development of Covid-19 vaccines, Thursday is a crucial date, STAT tells us. Nothing extraordinary is expected to happen when a committee of outside experts — known as the Vaccines and Related Biological Products Advisory Committee, or VRBPAC — meets for the first time to consider Covid-19 vaccines. But the meeting itself is a reassuring sign the Food and Drug Administration, which relies on VRBPAC for advice, plans to do what it usually does: Make decisions based not on political timetables but on data that show whether new vaccines are safe and effective.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.